AUTHOR=de la Salle Sara , Shah Dhrasti , Choueiry Joelle , Bowers Hayley , McIntosh Judy , Ilivitsky Vadim , Knott Verner 

TITLE=NMDA Receptor Antagonist Effects on Speech-Related Mismatch Negativity and Its Underlying Oscillatory and Source Activity in Healthy Humans

JOURNAL=Frontiers in Pharmacology

VOLUME=10

YEAR=2019

URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2019.00455

DOI=10.3389/fphar.2019.00455

ISSN=1663-9812

ABSTRACT=<p><bold>Background:</bold> Previous studies in schizophrenia have consistently shown that deficits in the generation of the auditory mismatch negativity (MMN) – a pre-attentive, event-related potential (ERP) typically elicited by changes to simple sound features – are linked to <italic>N</italic>-methyl-<sc>D</sc>-aspartate (NMDA) receptor hypofunction. Concomitant with extensive language dysfunction in schizophrenia, patients also exhibit MMN deficits to changes in speech but their relationship to NMDA-mediated neurotransmission is not clear. Accordingly, our study aimed to investigate speech MMNs in healthy humans and their underlying electrophysiological mechanisms in response to NMDA antagonist treatment. We also evaluated the relationship between baseline MMN/electrocortical activity and emergent schizophrenia-like symptoms associated with NMDA receptor blockade.</p><p><bold>Methods:</bold> In a sample of 18 healthy volunteers, a multi-feature Finnish language paradigm incorporating changes in syllables, vowels and consonant stimuli was used to assess the acute effects of the NMDA receptor antagonist ketamine and placebo on the MMN. Further, measures of underlying neural activity, including evoked theta power, theta phase locking and source-localized current density in cortical regions of interest were assessed. Subjective symptoms were assessed with the Clinician Administered Dissociative States Scale (CADSS).</p><p><bold>Results:</bold> Participants exhibited significant ketamine-induced increases in psychosis-like symptoms and depending on temporal or frontal recording region, co-occurred with reductions in MMN generation in response to syllable frequency/intensity, vowel duration, across vowel and consonant deviants. MMN attenuation was associated with decreases in evoked theta power, theta phase locking and diminished current density in auditory and inferior frontal (language-related cortical) regions. Baseline (placebo) MMN and underlying electrophysiological features associated with the processing of changes in syllable intensity correlated with the degree of psychotomimetic response to ketamine.</p><p><bold>Conclusion:</bold> Ketamine-induced impairments in healthy human speech MMNs and their underlying electrocortical mechanisms closely resemble those observed in schizophrenia and support a model of dysfunctional NMDA receptor-mediated neurotransmission of language processing deficits in schizophrenia.</p><sec><title>HIGHLIGHTS</title><list list-type="simple" prefix-word="simple"><list-item><label>-</label><p>Neural effects of NMDA receptor blockade on speech processing were assessed in a ketamine model.</p></list-item><list-item><label>-</label><p>Ketamine reduced MMN, theta power, theta phase locking factor and regional cortical current density.</p></list-item><list-item><label>-</label><p>Psychosis-like symptoms induced by ketamine were related to baseline (placebo) neural measures of speech processing.</p></list-item></list></sec>